|
|
Quest Diagnostics Inc (DGX) |
|
|
|
| |
DGX's Revenue Growth by Quarter and Year
Quest Diagnostics Inc's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| DGX Revenue (in millions $) |
FY 2024 |
FY 2023 |
FY 2022 |
FY 2021 |
| IV Quarter |
December |
-
|
2,288.00
|
2,333.00
|
2,744.00
|
| III Quarter |
September |
-
|
2,295.00
|
2,486.00
|
2,774.00
|
| II Quarter |
June |
2,397.00
|
2,338.00
|
2,453.00
|
2,550.00
|
| I Quarter |
March |
2,366.00
|
2,331.00
|
2,611.00
|
2,720.00
|
| FY |
|
4,763.00
|
9,252.00
|
9,883.00
|
10,788.00
|
| DGX Revenue second quarter 2024 Y/Y Growth Comment |
Quest Diagnostics Inc reported Revenue growth of 2.52% year on year in the second quarter 2024, to $ 2,397.00 millions, this is lower than Quest Diagnostics Inc's recent average Revenue growth of 3.58%.
Among companies who have reported second quarter 2024 results in the Medical Laboratories industry only one Company has achieved higher year on year Revenue results in the second quarter 2024. While Quest Diagnostics Inc' s Revenue increase of 2.52% ranks overall at the positon no. 205 in the second quarter 2024.
|
| DGX Revenue ( Y/Y Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
-1.93 % |
-14.98 % |
-8.59 % |
| III Quarter |
September |
- |
-7.68 % |
-10.38 % |
-0.43 % |
| II Quarter |
June |
2.52 % |
-4.69 % |
-3.8 % |
39.57 % |
| I Quarter |
March |
1.5 % |
-10.72 % |
-4.01 % |
49.29 % |
| FY |
|
- |
-6.38 % |
-8.39 % |
14.32 % |
DGX Revenue (Quarter on Quarter Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
-0.31 % |
-6.15 % |
-1.08 % |
| III Quarter |
September |
- |
-1.84 % |
1.35 % |
8.78 % |
| II Quarter |
June |
1.31 % |
0.3 % |
-6.05 % |
-6.25 % |
| I Quarter |
March |
3.41 % |
-0.09 % |
-4.85 % |
-9.39 % |
| FY (Year on Year) |
|
- |
-6.38 % |
-8.39 % |
14.32 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 46.83 % |
3.58 % |
-10.34 % |
| (Jun 30 2021) |
|
(Jun 30 2023) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 46.83 % |
3.58 % |
-10.34 % |
| (Jun 30 2021) |
|
(Jun 30 2023) |
|
| Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024 |
Quest Diagnostics Inc's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 52.49 % |
1.03 % |
-9.39 % |
| (Sep 30 2020) |
|
|
| DGX's II. Quarter Q/Q Revenue Comment |
Quest Diagnostics Inc achieved in the II. Quarter 2024 above company average sequential Revenue growth of 1.31%, to $ 2,397.00 millions, from $2,366.00 millions in the first quarter.
Within Medical Laboratories industry 12 other companies have achieved higher Revenue quarter on quarter growth. While Quest Diagnostics Inc's Revenue growth quarter on quarter, overall rank is 1021. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 52.49 % |
1.03 % |
-9.39 % |
| (Sep 30 2020) |
|
|
| DGX's II. Quarter Q/Q Revenue Comment |
Quest Diagnostics Inc achieved in the II. Quarter 2024 above company average sequential Revenue growth of 1.31%, to $ 2,397.00 millions, from $2,366.00 millions in the first quarter.
Within Medical Laboratories industry 12 other companies have achieved higher Revenue quarter on quarter growth. While Quest Diagnostics Inc's Revenue growth quarter on quarter, overall rank is 1021. |
|
Quest Diagnostics Inc's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
12 Months Ending
(Dec 31 2023) |
12 Months Ending
(Sep 30 2023) |
12 Months Ending
(Jun 30 2023) |
| Cumulative Revenue 12 Months Ending |
$ 9,346.00 |
$ 9,287.00 |
$ 9,252.00 |
$ 9,297.00 |
$ 9,488.00 |
| Y / Y Revenue Growth (TTM) |
-1.5 % |
-3.29 % |
-6.38 % |
-9.69 % |
-10.34 % |
| Year on Year Revenue Growth Overall
Ranking |
# 2069 |
# 2283 |
# 959 |
# 175 |
# 1095 |
| Seqeuential Revenue Change (TTM) |
0.64 % |
0.38 % |
-0.48 % |
-2.01 % |
-1.2 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 1226 |
# 1884 |
# 859 |
# 162 |
# 1022 |
| Cumulative Revenue growth
Comment |
Quest Diagnostics Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2024. If the fiscal year would end in Jun 30 2024, Quest Diagnostics Inc's annual Revenue decline would be -1.5% year on year to $9,346 millions.
In the Healthcare sector 278 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2069, from total ranking in previous quarter at 2283. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
46.83 % |
3.58 % |
-10.34 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
46.83 % |
3.58 % |
-10.34 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 12 |
| Sector |
# 172 |
| S&P 500 |
# 1226 |
|
| Cumulative Revenue growth
Comment |
Quest Diagnostics Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2024. If the fiscal year would end in Jun 30 2024, Quest Diagnostics Inc's annual Revenue decrease would be -1.5% year on year to $9,346 millions.
In the Healthcare sector 278 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2069, from total ranking in previous quarter at 2283. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
46.83 % |
3.58 % |
-10.34 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
46.83 % |
3.58 % |
-10.34 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 12 |
| Sector |
# 172 |
| S&P 500 |
# 1226 |
|
4.31%